NCT02355574View on ClinicalTrials.gov

5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results

TerminatedOBSERVATIONAL
Enrollment

301

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2021

Study Completion Date

July 31, 2021

Conditions
Cutaneous Melanoma
Trial Locations (3)

30342

Northside Hospital, Atlanta

40202

University of Louisville, Louisville

63103

Saint Louis University, St Louis

Sponsors
All Listed Sponsors
lead

Castle Biosciences Incorporated

INDUSTRY